NCT03713294 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03713294
Title	Dexamethasone, Elotuzumab, and Pomalidomide in Treating Patients With Refractory Multiple Myeloma
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Mayo Clinic
Indications	multiple myeloma
Therapies	Dexamethasone + Elotuzumab + Pomalidomide
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
Mayo Clinic in Florida		Jacksonville	Florida	32224-9980	United States	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT03713294Clinical Trial Detail